Schaeffer's Top Stock Picks for '25

Valeant Could Be On the Cusp of Another Surge Higher

The Canadian drugmaker landed a relatively rare bullish brokerage note

Managing Editor
Jan 5, 2018 at 9:19 AM
facebook X logo linkedin


Drug stock Valeant Pharmaceuticals International Inc (NYSE:VRX) is continuing its climb higher, after brokerage firm TD Securities raised its price target to $27 from $20 earlier. The firm is in the minority with its "buy" rating on VRX; currently, the stock sports just four "buy" or better ratings, compared to 10 "holds" and five "sells."  

VRX shares are up 1.3% at $23.36 in electronic trading, not far from their Jan. 3 annual high of $23.47. From a broader perspective, VRX has rallied more than 140% in the past nine months alone.

What's more, the security also sports a Schaeffer's Volatility Index (SVI) of 49%, which ranks in just the 12th percentile of its annual range. According to Schaeffer's Senior Quantitative Analyst Rocky White, the last (and only other) time VRX was trading near a 52-week high with an SVI this low, the security went on to rally nearly 32% over the next month.

In the options pits, data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) shows VRX's 10-day call/put volume ratio at an extreme 5.93, which ranks in the 100th percentile of its annual range. This suggests that calls have been purchased over puts at an annual-high pace.

However, some of those calls may have been bought as hedges. Short interest on VRX ramped up by 7% in the most recent reporting period, and now represents 11.1% of the equity's float. Given the stock's strongly bullish momentum of late, it's no surprise that these short sellers might be looking to limit losses via a call option hedge.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?